Description
The
cortisol [125I] assay system provides the quantitative in
vitro determination of cortisol in human serum. Cortisol can be assayed
in the range 0-1600 nmol/l (0-580 ng/ml). Each kit contains materials
sufficient for 100 assay tubes, permitting the construction of one
standard curve and assay of 42 unknowns and 1 control in duplicate.
Introduction
Cortisol is the main glucocorticoid which is
produced by the adrenal cortex. It regulates carbohydrate, protein, fat
and purine metabolism, electrolyte and water balance. Cortisol has a
role in blood pressure regulation and resolution of inflammation.
The determination of cortisol levels can be
used for diagnosing the functional disturbances of the
hypothalamus-pituitary-adrenal cortex (HPA) axis.
In normal individuals cortisol secretion has a
characteristic rhythm: the cortisol level is the highest in the morning,
by the evening it decreases to approximately half that level.
Principle of the method
This assay is based on the competition between
unlabelled cortisol and a fixed quantity of 125I-labelled
cortisol for a limited number of binding sites on cortisol specific
antibody. Allowing to react a fixed amount of tracer and antibody with
different amounts of unlabelled ligand the amount of tracer bound by the
antibody will be inversely proportional to the concentration of
unlabelled ligand. Upon addition of magnetizable immunosorbent the
antigen-antibody complex is bound on solid particles which are then
separated by either magnetic sedimentation or centrifugation. Counting
the radioactivity of solid phase enables a standard curve to be
constructed and samples to be quantitated.
Contents of the kit
|
1 vial |
TRACER, ready to use
11 ml, containing about 115 kBq 125I-cortisol
in buffer with 0.1% NaN3 |
|
6 vials |
STANDARDS, ready to use
0.5 ml per vial, containing 0, 40, 100, 250, 650, 1600
nmol/l in serum with 0.1% NaN3 |
|
1 vial |
ANTISERUM, ready to use
11 ml, containing polyclonal anti-Cortisol (rabbit) IgG
in buffer with 0.1% NaN3 |
|
1 vial |
CONTROL SERUM. Lyophilised human serum with 0.1% NaN3 |
|
1 bottle |
MAGNETIC MMUNOSORBENT (MIS), ready to use
55 ml, containing paramagnetic particles in buffer with
0.1% NaN3. |
| |
Quality certificate |
| |
Pack leaflet |
Materials and equipment required
Round
bottom polystyrene or polypropylene assay tubes, about 12 x 75 mm
Plastic film to cover tubes
Precision pipettes (10, 100 and 500 µl)
Vortex mixer
Magnetic separator (or, alternatively, centrifuge)
Decanting racks
Gamma counter
Recommended tools and equipment
Orbital
shaker
Repeating pipettes
Preparation of reagents
Add 500 µl
distilled water to the lyophilised control serum. Mix gently with
shaking or vortexing (foaming should be avoided). Ensure that complete
dissolution is achieved, and allow the solution to equilibrate at room
temperature for at least 20 minutes.
For
repeated use the rest of reagent can be stored at 4-8 oC for
two months.
Specimen collection and storage
Serum
samples can be prepared according to common procedures used routinely in
clinical laboratory practice.Sera can be stored at 2-8 oC for
two days after collection. For later analysis they should be stored
deep-frozen. Repeated freezing and thawing should be avoided. Do not use
lipemic, hemolyzed or turbid specimens.
Assay procedure
(For a quick guide refer to Table 1)
|
1 |
Equilibrate all reagents to room temperature |
|
2 |
Label duplicate tubes for total counts (T), zero standard
(Standard 1 = B0), standards (S2-6),
control (C) and samples (Sx). |
|
3 |
Mix all reagents and samples thorougly before use. Avoid
excessive foaming. |
|
4 |
Pipette 10 µl each of standards, control and samples into
the properly labelled tubes. |
|
5 |
Pipette 100 µl of tracer solution into all tubes. |
|
6 |
Pipette 100 µl of antiserum into all tubes except T. |
|
7 |
Thoroughly vortex mix all tubes except T for 2-5 seconds.
When having an orbital shaker, leave all tubes in the rack
holder, fix the holder onto the plate of the shaker, and shake
it gently for a few seconds. |
|
8 |
Incubate the tubes for 2 hours at room temperature. |
|
9 |
Place T tubes on a separate tube rack. Gently shake and
swirl the bottle containing magnetic immunosorbent until
homogeneity. Add 500 µl to each tube except T. When using a
single pipette, swirl the bottle of MIS after every 15-20 tubes.
With the use of a repeating pipette (e.g. Eppendorf), there is
no need for repeated homogenisation of MIS reagent. |
|
10 |
Thoroughly vortex mix all tubes and incubate them for 15
minutes at room temperature. |
|
11 |
Separate the bound fraction by using one of the following
procedures.
Magnetic separation
Attach the rack on to the magnetic separator base and ensure
that every tube is in contact with the base plate. Let the MIS
particles settle for 5 minutes. Do not remove the rack from the
separator base after the separation of the solid and liquid
phases. Pour off and discard the supernatant. Keeping the
separator inverted, place the tubes on a pad of absorbent tissue
and allow to drain for 2 minutes.
Centrifugation
Centrifuge all tubes for 15 minutes at 1500 g or greater.
Aspirate the supernatant taking care to avoid disturbing the
precipitate. |
|
12 |
Count the radioactivity of all tubes preferably not less
than 60 seconds |
|
13 |
Calculate the concentrations as described under
Calculation of results. |
Table
1. Assay Protocol, Pipetting Guide (all volumes in microliters)
|
Tubes |
T |
S1-S6 |
Sx |
C |
|
Standard |
|
10 |
|
|
|
Sample |
|
|
10 |
|
|
Control |
|
|
|
10 |
|
Tracer |
100 |
100 |
100 |
100 |
|
Antiserum |
|
100 |
100 |
100 |
|
Vortex mix
Incubate for 2 hours at room temperature |
|
Magnetic Immunosorbent |
|
500 |
500 |
500 |
|
Vortex mix
Incubate for 15 minutes at room temperature |
|
Place the tubes on the magnetic separator for 5 minutes
or centrifuge for 15 minutes at 1500 g |
|
Decant the supernatant and blot the tubes |
|
Count all tubes |
Calculation of results
The
assay data collected should be similar to those shown in Table 2.
Calculate the average counts per minute (CPM) for each pair of assay
tubes.
Calculate the percent B0/T for zero standard (S1) by using
the following equation:
| |
S1 (cpm) |
|
|
B0 / T % = |
——— |
x 100 |
| |
T (cpm) |
|
Calculate the normalized percent binding for each standard, control and
sample respectively by using the following equation:
| |
S2-6 [C, Mx] (cpm) |
|
|
B / B0 % = |
—————————— |
x 100 |
| |
S1 (cpm) |
|
For
simplicity, these values are uncorrected for non-specific binding (NSB).
This is enabled by low NSB being less than 3% of total count.
Using
semi-logarithmic graph paper plot B / B0% for each standard
versus the corresponding concentration of cortisol. Figure 1 shows a
typical standard curve.
Determine the cortisol concentration of the unknown samples by
interpolation from the standard curve. Do not extrapolate values beyond
the standard curve range. Automated data processing systems are also
available.
Table
2. Typical Assay Data
|
Tubes |
Counts
CPM1 |
Counts
CPM2 |
Counts
CPM |
B/T% |
B/B0 % |
|
T |
45762 |
45262 |
45512 |
|
|
|
S1 |
28959 |
30112 |
29536 |
64.9 |
100.0 |
|
S2 |
21096 |
20753 |
20925 |
46.0 |
70.8 |
|
S3 |
11349 |
11896 |
11623 |
25.5 |
39.4 |
|
S4 |
6054 |
6112 |
6083 |
13.4 |
20.6 |
|
S5 |
3293 |
3344 |
3319 |
7.3 |
11.2 |
|
S6 |
2078 |
2046 |
2062 |
4.5 |
7.0 |
|
C |
4935 |
5045 |
4990 |
11.0 |
16.9 |
Cortisol concentration nmol/l
Figure 1.
A typical standard curve
(Do not use to calculate sample values)
Conversion of SI units can be performed according to the
following formula:
1 nmol/l = 0.362 ng/ml
Characterization of the assay
Assay
parameters
|
NSB/T |
< 3 % |
|
B0 / T |
62.8 ±
5 % |
|
ED-50 |
130.5
± 18 nmol/l |
Specificity
Cross
reactivity of the cortisol antiserum in the kit with various substances
are shown below:
|
Basal steroid concentration |
20 ng/ml |
200 ng/ml |
|
Apparent cortisol concentration (ng/ml) |
|
Prednisolone |
19.1 |
166.5 |
|
Corticosterone |
7.9 |
27.0 |
|
Desoxycorticosterone |
5.0 |
12.3 |
|
17a-OH-progesterone |
7.6 |
14.4 |
|
Progesterone |
4.7 |
6.1 |
|
17a-estradiol |
< 3.6 |
< 3.6 |
|
Estriol |
< 3.6 |
3.6 |
|
Estrone |
< 3.6 |
3.9 |
|
Testosterone |
< 3.6 |
4.7 |
|
Dehydroepiandrosterone |
< 3.6 |
< 3.6 |
Sensitivity
10
nmol/l, defined as the concentration 2 standard deviations from the zero
standard.
Precision, reproducibility
|
Intra-assay
(1 assay in 21 rep.) |
Inter-assay
(17 assays in 2 rep.) |
|
Mean (ng/ml) |
CV % |
Mean
(ng/ml) |
CV % |
|
73.8 |
6.1 |
81.0 |
5.2 |
|
138.7 |
5.2 |
491.7 |
7.1 |
|
727.8 |
8.8 |
759.1 |
10.8 |
Recovery
Recovery was
defined as the measured increase expressed as percent of expected
increase upon spiking serum samples with known amount of cortisol.
Values for 11 serum samples spiked with cortisol at 3 levels were:
101 ± 10 %
Expected reference values
It is
recommended that each laboratory establish its own reference intervals.
As a guide,
morning
values: 160-620 nmol/l (58-225 ng/ml)
evening values: 90-400 nmol/l (33-145 ng/ml)
was
obtained from normal patients.
The
results obtained should only be interpreted in the context of the
overall clinical picture. None of the in vitro diagnostic kits can be
used as the one and only proof of any disease or disorder.
Additional information
Storage
Store
the reagents between 2 and 8 °C. At this temperature each reagent is
stable until expiry date. Pay special attention to preventing magnetic
immunosorbent suspension from freezing.
Availability
From
stock.
Shelf life
The
shelf life of kit reagents is 8 weeks from the date of manufacturing. To
make maximum benefit of long-term stability it is recommended to adjust
the date of ordering to labelling calendar issued each year. The actual
expiry date is given on package label and in the quality certificate.
Components from various lots or from kits of different manufacturers
should not be mixed or interchanged.
Precautions and warnings
This
kit should only be used for in vitro diagnostic purposes.
Radioactivity
This
kit contains radioactive material. Receipt, acquisition, possession, or
use of radioactive materials are subject to regulations, and a licence
of (inter)national authorizing bodies. It is the responsibility of the
user to ensure that local regulations or codes of practice are
satisfied.
Potentially infectious materials
Human
blood products provided as components of this product have been obtained
from donors tested individually and found negative for Human
Immunodeficiency Virus antibody (HIV-Ab) as well as for Hepatitis B
surface Antigen (HBsAg) using approved EIA methods.
Care
should always be taken when handling human specimens to be tested with
diagnostic kits. Even if the subject has been tested, no method can
offer complete assurance that Hepatitis B Virus, Human Immunodeficiency
Virus (HIV), or other infectious agents are absent, and all human blood
samples should be considered potentially infectious.
Chemical and other hazard
Some
components contain sodium azide (0.1% w/v) as an antimicrobial agent.
Dispose the waste by flushing it with copious amounts of water to avoid
build up of explosive metallic azides in copper and lead plumbing. The
total azide present in each pack is 80.5 mg.
 |
Use by |
 |
In vitro diagnostic medical device |
 |
Control |
 |
Batch code |
 |
Manufacturer |
 |
Standard |
 |
Caution, consult accompanying documents |
 |
Radioactive material |
 |
Magnetic immunosorbent |
 |
Biological risk |
 |
Temperature limitation
Store between 2-8 °C |
 |
Tracer |
 |
Consult operating instructions |
 |
Catalogue number |
 |
Antiserum |
|